Comments
Loading...

Chemomab Therapeutics

CMMBNASDAQ
Logo brought to you by Benzinga Data
$1.68
0.063.70%
At close: -
$1.64
-0.04-2.38%
After Hours: Dec 20, 5:27 PM EDT

Chemomab Therapeutics (NASDAQ:CMMB) Stock, Earnings Estimates, EPS, And Revenue

Chemomab Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Mar 6
EPS Estimate
$-0.010
Quarterly Revenue Estimate
Annual Revenue
(as of Sep 30)

Analyze the earnings history of Chemomab Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Chemomab Therapeutics (CMMB) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-14$-0.20$-0.01-1900.0 %
Sep 20232023-11-09$-0.34$-0.02-1600.0 %
Jun 20232023-08-14$-0.72$-0.8010.0 %
Mar 20232023-05-11$-0.80$-0.03-2566.7 %

Chemomab Therapeutics (CMMB) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Chemomab Therapeutics (NASDAQ:CMMB) reporting earnings?

A

Chemomab Therapeutics (CMMB) is scheduled to report earnings on March 6, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Chemomab Therapeutics (NASDAQ:CMMB)?

A

The Actual EPS was $-0.20, which missed the estimate of $-0.01.

Q

What were Chemomab Therapeutics’s (NASDAQ:CMMB) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch